Jane Street’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Buy
205,900
+122,100
+146% +$919K ﹤0.01% 6059
2025
Q4
$601K Buy
83,800
+59,600
+246% +$471K ﹤0.01% 7286
2025
Q3
$258K Sell
24,200
-33,600
-58% -$330K ﹤0.01% 9203
2025
Q2
$560K Sell
57,800
-7,100
-11% -$73.2K ﹤0.01% 6704
2025
Q1
$966K Buy
64,900
+53,100
+450% +$817K ﹤0.01% 5628
2024
Q4
$176K Sell
11,800
-40,700
-78% -$663K ﹤0.01% 8494
2024
Q3
$1M Buy
52,500
+24,500
+88% +$508K ﹤0.01% 5880
2024
Q2
$580K Sell
28,000
-56,500
-67% -$1.12M ﹤0.01% 6765
2024
Q1
$1.59M Buy
84,500
+12,600
+18% +$216K ﹤0.01% 4546
2023
Q4
$1.04M Buy
71,900
+17,900
+33% +$243K ﹤0.01% 5507
2023
Q3
$937K Sell
54,000
-10,300
-16% -$215K ﹤0.01% 5269
2023
Q2
$1.34M Sell
64,300
-22,100
-26% -$480K ﹤0.01% 4763
2023
Q1
$2.03M Sell
86,400
-7,000
-7% -$188K ﹤0.01% 3793
2022
Q4
$2.61M Sell
93,400
-16,200
-15% -$414K ﹤0.01% 3428
2022
Q3
$2.56M Buy
109,600
+9,800
+10% +$296K ﹤0.01% 3738
2022
Q2
$3.37M Sell
99,800
-55,400
-36% -$1.94M ﹤0.01% 3255
2022
Q1
$5.42M Buy
155,200
+21,490
+16% +$735K ﹤0.01% 2905
2021
Q4
$4.07M Buy
133,710
+43,740
+49% +$1.42M ﹤0.01% 3174
2021
Q3
$2.95M Buy
89,970
+59,890
+199% +$1.92M ﹤0.01% 3695
2021
Q2
$910K Buy
+30,080
New +$990K ﹤0.01% 6032

Other funds holding OGN

Jane Street's OGN Position: Q1 2026 in Review

Jane Street sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 2,007,556 shares — an estimated $15.1M sold.

Jane Street first reported a position in OGN in Q2 2021 and held it in 18 quarters. The position peaked at $14.4M in Q4 2025. 604 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Jane Street reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 2,007,556 Organon & Co shares in Q1 2026, an estimated $15.1M.
  • Jane Street first reported a position in Organon & Co in Q2 2021 and held it in 18 quarters.
  • Jane Street's Organon & Co position peaked at $14.4M in Q4 2025.
  • 604 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.